Clinical and biological implications of driver mutations in myelodysplastic syndromesElli Papaemmanuil, Peter J. Campbell, Moritz Gerstung et al.|Blood|2013Cited by 1.8k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring SideroblastsElli Papaemmanuil, Peter J. Campbell, Mario Cazzola et al.|New England Journal of Medicine|2011Cited by 1.2k
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Alexandra Smith, Takayuki Ishikawa et al.|Nature Medicine|2020Cited by 633
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort studyFrancesco Passamonti, Celestino Ferrandina, Chiara Cattaneo et al.|The Lancet Haematology|2020Cited by 553
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic SyndromesElisabetta Sauta, Matteo Giovanni Della Porta, Marie Robin et al.|Journal of Clinical Oncology|2023Cited by 109